Skip to content

H2020FP7HORIZON

Fundacion Publica Andaluza Progreso y Salud M.P.

Country
ESSpain
Defence projects
0
Projects, all programmes
33
As coordinator
16
EU contribution (CORDIS)
EUR 9,249,068
Active
2008 to 2025

Projects

33 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
EARLINESSEarly and sensitive detection of renal involvement and treatment responses in lupus patients using non-invasive biomarkersHORIZON2025CoordinatorEUR 226,441
EVERESTExtracellular Vesicle Research Exchanges for Advanced Biomarkers and TherapeuticsHORIZON2025ParticipantEUR 64,400
ASSESS-DHTASSESS-DHT: DEVELOPMENT AND HARMONISATION OF METHODOLOGIES FOR ASSESSING DIGITAL HEALTH TECHNOLOGIES IN EUROPEHORIZON2024ParticipantEUR 492,500
iRETINADevelopment of a multilayered and bioprinted iPSC-derived retinal model with use in preclinical and toxicological testingHORIZON2023CoordinatorEUR 206,641
SIGNATURESInGle cells iN AuToimmUne inflammatoRy disEasesHORIZON2023CoordinatorEUR 503,942
EP PerMedEuropean Partnership for Personalised MedicineHORIZON2023Third partyNot stated
HI-PRIXHealth Innovation Next Generation Payment & Pricing ModelsHORIZON2023ParticipantEUR 137,373
Onco-inflammationOrigin of genomic instability: Understanding the biological influence of inflammation in the initiation of pancreatic tumorigenesisH20202022CoordinatorEUR 172,932
OPENRESEARCHERS2223Open Researchers 2022-23HORIZON2022ParticipantEUR 11,513
CORE-MDCoordinating Research and Evidence for Medical DevicesH20202021ParticipantEUR 48,775
OPENRESEARCHERS2021Open Researchers 2021H20202021ParticipantEUR 6,942
OPENRESEARCHERS2020Open Researchers 2020H20202020ParticipantEUR 6,334
PB_dormancyInsertional mutagenesis to identify molecular mechanisms of breast cancer dormancy and metastasisH20202020CoordinatorEUR 172,932
ELIXIR-CONVERGEConnect and align ELIXIR Nodes to deliver sustainable FAIR life-science data management servicesH20202020ParticipantEUR 65,266
RoBEStudy of the role of BANK1 in antibody production and antibody-independent functions of B cells in SLEH20202019CoordinatorEUR 259,399
NECESSITYNEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patientsH20202019ParticipantEUR 50,000
OPENRESEARCHERS1819Open Researchers 2018-2019H20202018ParticipantEUR 9,332
WHO-ITU-mHealthWHO - ITU mHealth Hub in EUH20202017ParticipantEUR 1,218,300
OPENRESEARCHERSOpen ResearchersH20202016ParticipantEUR 7,204
NanoMedPhDNanomedicine Doctoral ProgrammeH20202016CoordinatorEUR 627,840

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.